The imprinting status of the SLC22A18AS gene, located in the human chromosome segment 11p15.5, was studied using PCR-SSCP analysis and fetal tissues from a battery of 17 abortuses. This gene showed monoallelic expression (genomic imprinting) in different tissues from two abortuses which were heterozygous for an SNP (c.473G>A) in its coding region. This gene was found to be paternally imprinted (maternally expressed) in five tissues namely lung, liver, brain, kidney and placenta from an abortus. The parental origin of the expressed allele could not be determined in the second abortus as both the mother and the abortus were heterozygous for the SNP. Since paternal blood samples from none of the 17 abortuses could be collected for DNA isolation, the mother's genotype was used to find the origin of the expressed allele. In order to understand the mechanism underlying imprinting of this gene, it was important to understand the nature of the epigenetic marks (imprints) on the two alleles of this gene. Since these epigenetic marks are generally observed in promoters or CpG islands associated with the imprinted genes, the promoters of the SLC22A18AS gene was characterized using transient transfection of putative SLC22A18AS promoter fragments cloned in the pGL3-Basic vector in human cells followed by luciferase reporter assay. Since the promoter of a gene lies upstream to the transcription start site (TSS), TSS of this gene was mapped. In silico approach revealed an EST (CB129046) which had an additional 39 bases upstream to the known mRNA sequence. TSS was then identified by the 5’ primer extension analysis. TSS was found to be 166 bases upstream to the 5’ end of this EST. In order to select cell lines for transient transfection of putative promoter constructs for promoter charaterization, RT-PCR analysis was used to see the expression of this gene in the following available cell lines in the lab: HuH7, HepG2, A549, HeLa, LNCaP and PC3. This gene was found to be maximally expressed in HepG2 cells. Expression of this gene was also observed in A549, HeLa, LNCaP and PC3 cells. HuH7, on the other hand, did not show any detectable expression of this gene. Based on the above data, HepG2 and A549 cells were selected for promoter characterization. Seven putative promoter constructs were transiently transfected in these cells and the promoter activity of different constructs was measured by luciferase assay. The assay identified two promoters for the gene: P1 promoter in a region from -855 to -254 bp and P2 promoter in a region from -1441 to -855. In order to see the presence of putative transcription factor binding sites in the upstream region of the gene, the MatInspector Professional program was used. The gene was found to be devoid of TATA and CCAAT boxes. Most of the putative transcription factor binding sites were present in a region from -855 to -254 bp which spans the P1 promoter, including a binding site for the Sp1 transcription factor. In order to see if Sp1 binds to the promoter of this gene, ChIP assay was performed. Sp1 was shown to bind the region harboring the P1 promoter. In order to see if Sp1 has a role in the regulation of this gene, Sp1 constructs were co-transfected with the SLC22A18AS P1 promoter construct in HepG2 and Sp1-null Drosophila SL2 cells. The results showed that the Sp1 has a positive regulation on the SLC22A18AS promoter activity. As stated earlier, epigenetic marks such as differential methylation of CpG dinucleotides in two alleles are associated with promoters of the genes. Since the promoters for SLC22A18AS were characterized, the presence of allele-specific differentially methylated regions (DMRs) associated with the promoters was investigated. In order to differentiate the two alleles in the promoter regions by SNPs, DNA sequence analysis of the promoter regions was performed in a battery of 17 abortuses to search for SNPs. Abortus no. 3 showed heterozygosity for a C to A change at nucleotide position -445 in the P1 promoter region, while abortus no. 2 showed heterozygosities for G to A and A to G changes at nucleotide positions -919 and -1321 respectively in the P2 promoter region. The alleles in the abortus no. 3 were designated as allele C and allele A. The alleles in abortus no. 2 were designated as allele GG and allele AA. Once the two alleles were differentiated by these SNPs, identification of DMRs was performed using sodium bisulfite genomic DNA sequencing. Genomic DNA from the abortus no. 3 was taken for the identification of DMR in the P1 promoter region, while genomic DNA from abortus no. 2 was taken for the identification of DMR in the P2 promoter region. Sodium bisulfite genomic DNA sequencing of the P1 promoter region showed heavy methylation of both the alleles. No DMR was observed in this region. Sodium bisulfite genomic DNA sequencing of the P2 promoter region using DNA from abortus no. 2 did not show any differential methylation of the two alleles. However, like the P1 promoter region, the P2 promoter region was also heavily methylated. In order to see the methylation status of both the promoter regions in human sperms, sperm DNA from an unrelated healthy volunteer was also subjected to sodium bisulfite genomic sequencing. A dense methylation was observed in both the promoter regions of the gene. Heavy methylation of CpG dinucleotides in these regions corroborates the imprinting result for this gene. Since the methylation epigenetic mark is also known to be associated with CpG islands, CpG Plot/CpG Report analysis was used to identify CpG islands in this gene. The analysis showed the presence of two CpG islands, CpG I and CpG II, in the second intron of the gene. As the CpG I island is known to lack methylated CpGs (Ali et al., unpublished result from our lab), a DMR was sought for the CpG II island region. Heterozygosity was ascertained in this region by sequencing DNA from 17 abortuses. However, none of the abortuses showed heterozygosity. It was reasoned that if there is a differential methylation of the two alleles in this region, half of the clones (alleles) should be unmethylated, and the other half should show methylation. Therefore, DNA from abortus no. 3 was randomly chosen for sodium bisulfite genomic sequence anaylsis to identify DMR. The CpG II island showed heavy methylation. However, a DMR was not identified. In order to see the methylation status of the CpG II island in human sperms, sperm DNA from an unrelated healthy volunteer was also subjected to sodium bisulfite genomic sequencing. Almost all the CpG sites showed methylation. The observation of a dense methylation of both the promoters and CpG II island suggested that methylation has a role in the expression of this gene. In order to confirm this observation, A549 and HuH7 cells were treated with a methyltransferase inhibitor, 5-aza-2’-deoxycytidine. 5-Aza-2’-deoxycytidine treatment in HuH7 cells restored the expression of this gene. Further, the expression of this gene was increased in A549 cells following the drug treatment. These results suggested that DNA methylation has a definite role in the modulation of expression of the SLC22A18AS gene. Histone acetylation is another key epigenetic player which is known to have a role in the expression of genes. In order to study the role of the histone acetylation, HuH7 and A549 cells were treated with TSA, a histone deacetylase inhibitor. Treatment of HuH7 and A549 cells with TSA didn’t have any effect on the expression of this gene. On the other hand, the expression of TPA, a gene shown to be regulated by TSA earlier, increased following the TSA treatment in both cell lines. These results suggested that histone acetylation doesn’t have any effect on the expression of this gene. Based on this observation, it was reasoned that histone acetylation is not associated with the imprinting of this gene. Therefore, we did not look for the allele-specific acetylation of histones in this gene. The SLC22A18AS gene has a weak ORF of 253 amino acids as the translation intiation site does not contain a consensus Kozak sequence for efficient translation. In order to determine if it codes for a protein, Western blot analysis was performed using lysates from A549 cells and human fetal liver tissue, and a polyclonal antibody raised in a rabbit against a bacterially expressed SLC22A18AS protein fragment from amino acids 138 to 245. The Western blot result was negative. It was reasoned that this gene might be expressed at a low level and therefore its expression could not be detected by Western blot analysis. Immunoprecipitation was then performed to enrich the SLC22A18AS protein in the lysates followed by Western blot analysis. SLC22A18AS was shown to be expressed as a 30 kDa band in the immunoprecipiates from A549 cell and human fetal liver tissue lysates. The subcellular localization of this gene was studied by immunofluorescence. The fluorescence immunolocalization was performed on A549 cells with anti-SLC22A18AS antibody. The SLC22A18AS protein was found to be localized in the cytoplasm of A549 cells.

A maioria dos casos de puberdade precoce central (PPC) em meninas permanece idiopática. A hipótese de uma causa genética vem se fortalecendo após a descoberta de alguns genes associados a este fenótipo, sobretudo aqueles implicados com o sistema kisspeptina (KISS1 e KISS1R). Entretanto, apenas casos isolados de PPC foram relacionados à mutação na kisspeptina ou em seu receptor. Até recentemente, a maioria dos estudos genéticos em PPC buscava genes candidatos selecionados com base em modelos animais, análise genética de pacientes com hipogonadismo hipogonadotrófico, ou ainda, nos estudos de associação ampla do genoma. Neste trabalho, foi utilizado o sequenciamento exômico global, uma metodologia mais moderna de sequenciamento, para identificar variantes associadas ao fenótipo de PPC. Trinta e seis indivíduos com a forma de PPC familial (19 famílias) e 213 casos aparentemente esporádicos foram inicialmente selecionados. A forma familial foi definida pela presença de mais de um membro afetado na família. DNA genômico foi extraído dos leucócitos do sangue periférico de todos os pacientes. O estudo de sequenciamento exômico global realizado pela técnica ILLUMINA, em 40 membros de 15 famílias com PPC, identificou mutações inativadoras em um único gene, MKRN3, em cinco dessas famílias. Pesquisa de mutação no MKRN3 realizada por sequenciamento direto em duas famílias adicionais (quatro pacientes) identificou duas novas variantes nesse gene. O MKRN3 é um gene de um único éxon, localizado no cromossomo 15 em uma região crítica para a síndrome de Prader Willi. O gene MKRN3 sofre imprinting materno, sendo expresso apenas pelo alelo paterno. A descoberta de mutações em pacientes com PPC familial despertou o interesse para a pesquisa de mutações nesse gene em 213 pacientes com PPC aparentemente esporádica por meio de reação em cadeia de polimerase seguida de purificação enzimática e sequenciamento automático direto (Sanger). Três novas mutações e duas já anteriormente identificadas, incluindo quatro frameshifts e uma variante missense, foram encontradas, em heterozigose, em seis meninas não relacionadas. Todas as novas variantes identificadas estavam ausentes nos bancos de dados (1000 Genomes e Exome Variant Server). O estudo de segregação familial em três dessas meninas com PPC aparentemente esporádica e mutação no MKRN3 confirmou o padrão de herança autossômica dominante com penetrância completa e transmissão exclusiva pelo alelo paterno, demonstrando que esses casos eram, na verdade, também familiares. A maioria das mutações encontradas no MKRN3 era do tipo frameshift ou nonsense, levando a stop códons prematuros e proteínas truncadas e, portanto, confirmando a associação com o fenótipo. As duas mutações missenses (p.Arg365Ser e p.Phe417Ile) identificadas estavam localizadas em regiões de dedo ou anel de zinco, importantes para a função da proteína. Além disso, os estudos in silico dessas duas variantes demonstraram patogenicidade. Todos os pacientes com mutação no MKRN3 apresentavam características clínicas e hormonais típicas de ativação prematura do eixo reprodutivo. A mediana de idade de início da puberdade foi de 6 anos nas meninas (variando de 3 a 6,5) e 8 anos nos meninos (variando de 5,9 a 8,5). Tendo em vista o fenômeno de imprinting, análise de metilação foi também realizada em um subgrupo de 52 pacientes com PPC pela técnica de MS-MLPA, mas não foram encontradas alterações no padrão de metilação. Em conclusão, este trabalho identificou um novo gene associado ao fenótipo de PPC. Atualmente, mutações inativadoras no MKRN3 representam a causa genética mais comum de PPC familial (33%). O MKRN3 é o primeiro gene imprintado associado a distúrbios puberais em humanos. O mecanismo preciso de ação desse gene na regulação da secreção de GnRH necessita de estudos adicionais / Most cases of central precocious puberty (CPP) in girls remain idiopathic. The hypothesis of a genetic cause has been strengthened after the discovery of some genes associated with this phenotype, particularly those involved with the kisspeptin system (KISS1 and KISS1R). However, genetic defects in KISS1 and its receptor are rare and have been identified in only a few patients with CPP.over the past years. To date, most genetic studies in CPP was based mainly on a candidate gene approach, including genes selected in animal studies, human models of patients with hypogonadotropic hypogonadism or in genome wide association studies. In the present study, we used whole exome sequencing, a more advanced method of sequencing, to identify variants associated with CPP. Thirty-six patients with the familial form of CPP (19 families) and 213 apparently sporadic cases were initially selected. The familial form was defined by the presence of more than one member affected in the family. Genomic DNA was extracted from peripheral blood leukocytes in all patients. Whole exome sequencing performed by ILLUMINA technique in 40 members of 15 families with CPP, identified inactivating mutations in a single gene, MKRN3, in five out of these families. Analysis of MKRN3 mutations performed by automatic sequencing in two additional families (four patients) identified two novel mutations. MKRN3 is an introless gene located on chromosome 15, in the Prader Willi syndrome critical region, and it is expressed only by the paternal allele due to the maternal imprinting. Following the initial findings, we searched for MKRN3 mutations in 213 patients with apparently sporadic CPP using polymerase chain reaction followed by direct enzymatic purification and automated sequencing (Sanger). Three new mutations and two previously reported, including four frameshifts and one missense variant was identified in six unrelated girls with CPP. All variants were not described in the two databases (1000 Genomes and Exome Variant Server). The familial segregation analysis performed in three out of these girls with apparently sporadic CPP and MKRN3 mutations confirmed the autosomal dominant inheritance with complete penetrance and exclusive transmission through the paternal allele, revealing familial inheritance in apparently sporadic cases. Most of these MKRN3 mutations were frameshifts or nonsense, leading to premature stop codons and truncated proteins, thus demonstrating positive genotype- phenotype correlation. The two missense mutations (p.Arg365Ser and p.Phe417Ile) identified were located within zinc finger motifs, regions predicted to be essential for the protein function. Besides that, all missense mutations were predicted to be pathogenic by in silico analysis. All patients carrying MKRN3 mutations exhibited typical clinical and hormonal features of premature activation of the reproductive axis. The median age of puberty onset was 6.0 years in girls (ranging from 3.0 to 6.5) and 8.0 years in boys (ranging from 5.9 to 8.5). In view of the imprinting phenomenon, methylation analysis was also performed in a subgroup of 52 patients with CPP by MSMLPA technique, but no methylation abnormalities were detected. In conclusion, our work has identified a new gene associated with CPP. Currently, inactivating mutations in MKRN3 represent the most common genetic cause of familial CPP (33%). MKRN3 is the first imprinted gene associated with pubertal disorders in humans. However, its precise mechanism of action in the regulation of GnRH secretion needs further studies

A idade normal para início da puberdade em meninas varia bastante, de 8 a 13 anos, e os genes envolvidos nesse controle são parcialmente conhecidos. Fatores ambientais, como alimentação e exposição a disruptores endócrinos, contribuem para essa variabilidade, de modo que genes modulados epigeneticamente podem justificar parte da complexidade desse processo. O termo epigenética se refere às modificações na expressão gênica que não são causadas por alterações na sequência do DNA. A metilação do DNA é o mecanismo epigenético mais bem estudado. Na última década surgiram evidências demonstrando a relação entre metilação do DNA e desenvolvimento puberal. Em fêmeas de roedores, a hipermetilação do DNA levou à puberdade precoce. Em humanos, a puberdade precoce central (PPC) familial causada por mutações nos genes MKRN3 e DLK1 é considerada um defeito do imprinting, fenômeno epigenético no qual apenas um dos alelos parentais é expresso, estando o outro metilado e inativo. Além disso, um conceito atual propõe que o início da puberdade requer a repressão epigenética de fatores inibidores do eixo gonadotrófico. Recentemente, genes zinc finger (ZNF) foram relacionados ao processo puberal, e muitos deles codificam repressores transcricionais. Neste trabalho, estudamos a metilação do DNA do sangue periférico de 10 pacientes do sexo feminino com PPC familial (casos índices) e 33 meninas com desenvolvimento puberal normal (15 pré-púberes e 18 púberes), usando a plataforma Human Methylation 450 BeadChip. Duas pacientes tinham PPC de causa genética (uma com mutação no MKRN3 e outra com deleção no DLK1) e oito tinham PPC idiopática, sem mutações identificadas pelo sequenciamento exômico global. Cento e vinte regiões diferencialmente metiladas foram identificadas entre as meninas saudáveis pré-púberes e púberes, estando 74% delas no cromossomo X. Apenas uma região mostrou-se hipometilada no grupo púbere e, de maneira importante, contém a região promotora do ZFP57, fator necessário para manutenção do imprinting. Uma vez que a hipermetilação nas regiões promotoras dos genes é relacionada à inibição transcricional, o achado de hipermetilação global do DNA na puberdade sugere que haja inibição de fatores inibidores do eixo gonadotrófico, o que resultaria no início do processo puberal. O receptor estrogênico destacou-se como um fator transcricional que se liga a sete genes diferencialmente metilados entre os controles pré-púberes e púberes. As pacientes com PPC apresentaram mais sítios CpG hipermetilados tanto na comparação com as meninas pré-púberes (81%) quanto púberes (89%). Há doze genes ZNF contendo sítios CpG hipermetilados na PPC. Não foram encontradas anormalidades de metilação nos genes MKRN3 e DLK1 nem em suas regiões regulatórias. Em conclusão, este estudo evidenciou hipermetilação global do DNA em meninas com puberdade normal e precoce, sugerindo que esse padrão é uma marca epigenética da puberdade. Pela primeira vez, mudanças no metiloma de pacientes com PPC foram descritas. Modificações na metilação de vários genes ZNF parecem compor a complexa rede de mecanismos que leva ao início da puberdade humana / Normal puberty initiation varies greatly among girls, from 8 to 13 years, and the genetic basis for its control is partially known. Environmental factors, such as nutrition and exposure to endocrine disruptors, contribute to this variance, and epigenetically modulated genes may justify some of the complexity observed in this process. Epigenetics refers to alterations in gene expression that are not caused by changes in DNA sequence itself. DNA methylation is the best studied epigenetic mechanism. In the last decade, evidence has emerged showing the relationship between DNA methylation and pubertal development. In female mice, DNA hypermethylation led to precocious puberty. In humans, familial central precocious puberty (CPP) caused by mutations in the MKRN3 and DLK1 genes is considered a disorder of imprinting, an epigenetic phenomenon in which only one parental allele is expressed, and the other allele is methylated and inactive. In addition, animal studies indicated that pubertal timing requires epigenetic repression of inhibitory factors of the gonadotrophic axis. Recently, zinc finger genes (ZNF) were related to pubertal development, many of which encode transcriptional repressors. In the present study, we analyzed the DNA methylation of peripheral blood samples from 10 female patients with familial CPP (index cases) and 33 girls with normal pubertal development (15 pre-pubertal and 18 pubertal), using the Human Methylation 450 BeadChip assay. Genetic CPP was diagnosed in two patients (one with a MKRN3 mutation and the other with a DLK1 deletion). The remaining eight cases with idiopathic CPP were previously evaluated by whole exome sequencing and no causative mutations were identified so far. We evidenced 120 differentially methylated regions between pre-pubertal and pubertal healthy girls, and 74% of them were located at the X chromosome. Only one genomic region was hypomethylated in the pubertal group. Of note, it contains the promoter region of ZFP57, an important factor for imprinting maintenance. As DNA hypermethylation in gene promoters is related to gene silencing, the finding of global DNA hypermethylation in puberty suggests inhibition of inhibitory factors of the hypothalamic-pituitary-gonadal axis that results in puberty onset. Importantly, the estrogen receptor was identified as a transcriptional factor that binds to seven differentially methylated genes associated with pubertal process. Patients with CPP exhibited more hypermethylated CpG sites compared to both pre-pubertal (81%) and pubertal (89%) controls. Twelve ZNF genes were recognized as having hypermethylated CpG sites in CPP. The methylation analyses of MKRN3 and DLK1 genes showed no abnormalities. In conclusion, this study revealed a widespread DNA hypermethylation in girls with normal and precocious puberty, suggesting that this pattern can be an epigenetic signature of puberty. For the first time, changes in the methylome of patients with CPP were described. We highlight that alterations in methylation levels of several ZNF genes may impact the onset of human puberty

La croissance fœtale et postnatale est un processus finement régulé par des facteurs génétiques, épigénétiques et environnementaux complexes. Le système des IGFs (insulin-like growth factors) est l’un des acteurs principaux jouant un rôle crucial dans le développement fœtal et postnatal. Chez l’humain, plusieurs mutations des gènes IGF1 et IGF-1R ainsi qu’une mutation d’origine paternelle d’IGF2 ont été rapportées chez des patients ayant un retard de croissance intra-utérin (RCIU) qui peut persister et/ou s’aggraver en postnatal. Par ailleurs, les phénomènes épigénétiques comme la méthylation de l’ADN et le code histone jouent également un rôle prépondérant dans le développement fœtal et postnatal. L’empreinte parentale, mise en place grâce à des marques épigénétiques, est un des mécanismes important pour le développement fœtal. Chez l’humain, une anomalie de régulation de gènes soumis à empreinte parentale est associée à plusieurs syndromes de retard de croissance intra-utérin et postnatal ou à l’inverse de croissance excessive. Ce travail comporte deux parties: nous nous sommes dans un premier temps particulièrement intéressés à l’étude génétique et épigénétique de la région 11p15.5 et de son centre d’empreinte régulant le domaine IGF2/H19 dans une population de patients ayant une croissance excessive ou bien un RCIU (syndromes de Beckwith-Wiedemann et Silver-Russell respectivement), afin de mieux comprendre la régulation de ce domaine. Puis, la deuxième partie de notre étude a porté sur l’identification de nouvelles causes génétiques et épigénétiques de syndrome de Silver-Russell, altérant l’expression d’IGF2 mais n’étant pas directement secondaires à un défaut moléculaire de la région 11p15.5. / Fetal and postnatal growth is a process finely regulated by genetic, epigenetic and environmental complex. The IGFs system (insulin-like growth factors) is one of the main actors playing a crucial role in fetal and postnatal development. In humans, several mutations of IGF1 and IGF-1R genes and a paternal IGF2 mutation have been reported in patients with intrauterine growth restriction (IUGR), which can persist and/or worsen in postnatal life. Moreover, epigenetic phenomena such as DNA methylation and histone code also play a major role in fetal and postnatal development. Genomic imprinting, established due to epigenetic marks, is one of the major mechanisms for fetal development. In humans, abnormal regulation of genes subject to imprinting is associated with several syndromes of intrauterine and postnatal growth restriction or conversely excessive growth. This work has two parts: we initially particularly interested in the genetic and epigenetic study of the 11p15.5 region and its imprinting control region regulating the IGF2/H19 domain in a population of patients with overgrowth or IUGR (Beckwith-Wiedemann syndrome and Russell-Silver respectively), to better understand the regulation of this area. Then, the second part of our study focused on the identification of new genetic and epigenetic causes of Silver-Russell syndrome, altering the expression of IGF2, without being directly caused by a molecular defect of 11p15.5 region.

Hierdie verhandeling bestaan uit die ongepubliseerde manuskrip (gedigte) ʼn blaar hierdie boot, ʼn mini-verhandeling en ʼn tuisvervaardigde CD met ʼn paar gedigte. Die studie bespreek teoretiese terme en begrippe soos outoëtnografie, individuasie en vaslegging (imprinting), uit die vakgebiede van Sielkunde, Sosiologie, Opvoedkunde en Kommunikasiekunde. Die toepaslikheid van hierdie terme ten opsigte van geselekteerde literêre tekste word genoem en geïllustreer aan die hand van spesifieke skrywers. Daar word kortliks gekyk na die verstradisies van Sjina en Japan om die verwantskap met die Afrikaanse gedigte vas te stel. Sogenaamde “close reading” word geteleskopeer op geselekteerde verse uit ʼn blaar hierdie boot. ENGLISH : This dissertation consists of an unpublished anthology of poetry, ʼn blaar hierdie boot and a dissertation of limited scope, together with a home-recorded CD of poems. The study takes stock of theoretical terms and concepts like autoethnography, individuation and imprinting from the disciplines of Psychology, Sociology, Education and Communication. The relevance of these terms regarding selected literary texts is illustrated by the mention of specific authors and poets. A brief view on poetry traditions in China and Japan is offered, to illustrate the relation to Afrikaans poetry in general and the candidate’s poems in particular. So-called close reading is applied to selected poems from ʼn blaar hierdie boot Additional information available on a CD, stored at the Merensky Library on Level 3 Copyright / Dissertation (MA)--University of Pretoria, 2010. / Afrikaans / unrestricted

[pt] Neste trabalho, polímeros de impressão molecular (MIP) foram desenvolvidos para aplicação em procedimentos de extração em fase sólida (SPE) visando separar e concentrar quercetina (flavonóide), piraclostrobina (pesticida) e kanamicina (antibiótico) em amostras contendo substâncias interferentes na determinação dos analitos-alvo. A seletividade em relação aos analitos de interesse foi conseguida pela interação específica dessas espécies químicas com os sítios de reconhecimento dos polímeros. A produção desses MIPs foi baseada na polimerização em bulk e, de modo a se comprovar a efetividade dos mesmos, o desempenho destes foram comparados com polímeros não-impressos (NIP) correspondentes, que foram produzidos sem o uso da molécula-molde. Os procedimentos para síntese são simples e o material produzido é quimicamente resistente nas condições de uso. A caracterização do material produzido foi feita por meio de microscopia de varredura eletrônica (MEV) e espectrometria de absorção na região do infravermelho (IV). O MIP preparado com quercetina foi empregado na extração seletiva deste flavonóide em amostras de urina e de suplemento alimentar e permitiu a obtenção de limite de detecção de 4,58 x 10-8 mol L-1 usando espectrofotometria de absorção no UV-vis com recuperações superiores a 90 porcento e separação efetiva de outros flavonóides como a flavona e naringenina. O MIP preparado com piraclostrobina foi usado na análise de amostra de água de rio e urina e permitiu o alcance de limite de detecção de 4,6 x 10-9 mol L-1, usando detecção por espectrofluorimetria, e recuperações maiores que 90 porcento na presença de outros pesticidas da classe das estrobilurinas. Para o MIP preparado com kanamicina, o limite de detecção alcançado usando detecção com sonda de nanopartículas fluorescentes foi 9 ng mL-1 (1,5 x 10-8 mol L-1) com aplicação na análise de urina e vacina contra febre amarela com recuperações maiores a 90 porcento. / [en] In this work, molecularly imprinted polymers (MIPs) have been developed for application procedures for solid phase extraction (SPE) in order to separate and concentrate quercetin (flavonoid), pyraclostrobin (pesticide) and kanamycin (antibiotic) in samples containing interfering substances in the determination of target analytes. The selectivity in respect of analytes has been achieved by specific binding of these chemical species with the recognition sites of the polymers. The production of MIP polymerization was based on "bulk" and in order to prove the effectiveness thereof, the performance of these polymers were compared with non-printed (NIP) thereof, that were produced without the use of template molecule. The procedures for synthesis are simple and relatively low cost and is chemically resistant material produced under the conditions of use. The characterization of the material produced was done by scanning electron microscopy (MEV), absorption spectroscopy in the infrared region and CHN elemental analysis. The MIP prepared with quercetin was used for the selective extraction of flavonoids in urine samples and dietary supplement and allowed to obtain a detection limit of 4,58 x 10-8 mol L-1 using absorption spectrophotometry in the UV-vis with recoveries exceeding 90 percent and effective separation of other flavonoids such as naringenin and flavone. The MIP prepared with pyraclostrobin was used to analyze samples of urine and river water and allowed to reach the detection limit of 4,6 x 10-9 mol L-1, detection using spectrofluorimetry and recoveries greater than 90 percent in presence of other pesticides from the class of strobilurins. For the MIP prepared with kanamycin, the detection limit using detection with fluorescent nanoparticles probe was 9 ng mL-1 (1,5 x 10-8 mol L-1) application to the analysis of urine and yellow fever vacine with recoveries greater than 90 percent.

L’impression moléculaire de polymères est une technique utile pour créer des récepteurs artificiels capables de lier sélectivement des substrats. Cette propriété de reconnaissance rend les polymères à empreintes moléculaires particulièrement intéressants pour développer des catalyseurs macromoléculaires. Notre objectif a ainsi été d’accéder à un catalyseur supramoléculaire recyclable et capable d’oxyder des dérivés du soufre dans des conditions hétérogènes en présence d’un oxydant doux et éco-compatible tel que le peroxyde d’hydrogène. Compte-tenu de l’engagement du laboratoire dans la lutte contre les armes chimiques, nous avons décidé d’orienter nos travaux vers la mise au point d’un système catalytique qui serait utile pour la décontamination de surfaces ou de matériels, suite à l’exposition à certains composés dont la détoxification passe par l’oxydation sélective d’un sulfure. Nous avons ainsi préparé un MIP à base de porphyrine dont nous avons testé l'efficacité dans l'oxydation de divers sulfures d’intérêt. Les conditions douces utilisées pour la catalyse ont ainsi permis de contrôler le degré d’oxydation d’un simulant de l’ypérite, en obtenant avec une très grande sélectivité le dérivé sulfoxyde, sans que le dérivé sulfone qui serait tout aussi toxique que l’arme chimique elle-même ne se forme. Aves des structures plus proches de celle du VX, nous avons montré qu’il était possible d’oxyder régiosélectivement le soufre, et mis en évidence l’intérêt de ce procédé pour faciliter le clivage d’une liaison C-S. Cette approche représente donc une stratégie de décontamination intéressante qu’il conviendra d’évaluer dans le cas de véritables agents de guerre chimique. / Molecular imprinting polymer is a useful technique for creating artificial receptors able of selectively binding substrates. These recognition properties are particularly interesting for developing macromolecular catalysts. Our aim was to access to a reusable supramolecular catalyst able of oxidizing sulfur derivatives under heterogeneous conditions in the presence of a mild and eco-sustainable oxidant such as hydrogen peroxide. Given the expertise of the team, we decided to focus our work on the development of a catalytic system for the decontamination of surfaces or equipment, after an exposure to compounds that can be detoxified by a selective oxidation of sulfides. Thus, we prepared a porphyrin-based MIP that we tested in the oxidation of various sulfides. The mild conditions used for the catalysis allowed a control of the oxidation degree of a simulant of yperite, leading to a great selectivity the sulfoxide derivative, and avoiding the toxic sulfone formation. With other structures similar to VX, we showed that it is possible to regioselectively oxidize the sulfur atom, and highlighted the interest of this process to facilitate the cleavage of a C-S bond. This approach is then an interesting decontamination strategy that will be evaluated in the future to the case of true chemical warfare agents.

Lysophosphatidic acid (LPA) influences many physiological processes, such as brain and vascular development. It is associated with several diseases including ovarian cancer, breast cancer, prostate cancer, colorectal cancer, hepatocellular carcinoma, multiple myeloma atherosclerotic diseases, cardiovascular diseases, pulmonary inflammatory diseases and renal diseases. LPA plasma and serum levels have been reported to be important values in diagnosing ovarian cancer and other diseases. However, the extraction and quantification of LPA in plasma are very challenging because of the low physiological concentration and similar structures of LPA to other phospholipids. Many previous studies have not described the separation of LPA from other phospholipids, which may make analyses more challenging than necessary. We developed an SPE extraction method for plasma LPA that can extract LPA at high purity. We also developed an HPLC post-column fluorescence detection method that allows the efficient quantification of LPA. These methods were used in a clinical study for ovarian cancer diagnosis to help validate LPA as a biomarker of ovarian cancer. Moreover, molecular imprinted polymers (MIPs) were designed and synthesized as material for the improved extraction of LPA. Compared to the commercially available materials, the MIP developed shows enhanced selectivity for LPA. The extraction was overall relatively more efficient and less labor-intensive.

[pt] Nanopartículas de ouro dispersas em água (AuNPs-H) e nanopartículas de ouro na presença dos surfactantes brometo de cetiltrimetilamônio (AuNPs-CTAB) e brometo de didecildimetilamônio (AuNPs-C10DAB) foram sintetizadas e caracterizadas por diversas técnicas. As variações nos perfis espectrais no UV-Vis dessas nanopartículas foram estudadas levando-se em consideração a intensidade e o comprimento de onda máximo da banda de ressonância plasmônica de superfície localizada (LSPR); foram acompanhadas em função do tempo para nanopartículas estocadas sob refrigeração (4 graus celsius) com as mantidas na temperatura ambiente (27 graus celsius). Um comportamento anômalo (mais instável) foi observado para AuNPs-C10DAB na concentração 1,0 ×10-4 mol L-1. As suas atividades catalíticas também foram avaliadas na presença de 4-nitrofenol e verificou-se que a cinética mais efetiva foi do sistema sem surfactante. Finalmente, um estudo de interação com aminoglicosídeos (AMG) foi feito visando o uso das nanopartículas como sonda analítica. Todavia, somente AuNPs-H apresentaram resultados satisfatórios, o que indica que o surfactante impede que o AMG se aproxime da superfície das nanopartículas, visto que, em concentrações mais elevadas de CTAB ou C10DAB, não há variação significativa no sinal original da sonda quando o AMG está presente. Um método analítico foi desenvolvido baseado na interação AuNPs-H-gentamicina e AuNPs-H-neomicina a partir da otimização dos parâmetros: concentração de AuNPs-H, tampão, tempo de medição e faixa de concentração de AMG. Na condição ajustada para sondagem quantitativa, cada dispersão de trabalho foi constituída por 40 porcento v/v (1,2 × 10-9 mol L-1) de AuNPs-H 1,0 mL de tampão citrato pH 4,0 (1,0 × 10-2 mol L-1) e volume final de 5,0 mL ajustado pela adição água ultrapura, após micro-volumes apropriados de soluçãoestoque de AMG (exceto na dispersão branco) ou de amostras adicionadas. O monitoramento da variação dos perfis espectrais foi feito em 511 e em 681 nm, habilitando a construção de curvas analíticas em 681, e na razão (681/511). Para gentamicina, a faixa linear variou de 0,6 a 600 microgramas L-1 com o limite de detecção (LD) de 0,06 microgramas L-1. Para neomicina, faixa linear foi de 7,3 a 550 microgramas L-1, tendo LD de 6,2 microgramas L-1. A aplicação do método foi feita determinando-se gentamicina (fortificação) em leite integral, e neomicina em solução controle (amostra aquosa simulada), medicamento e em saliva. Para habilitar a seletividade do método foi necessária a utilização de extração em fase sólida (SPE) em cartuchos comercias empacotados com polímero de impressão molecular de AMG. Em amostras de leite (40 microlitros), após limpeza e SPE, foi possível quantificar 1,72 mais ou menos 0,03 microgramas de gentamicina, o equivale a 39,1 mais ou menos 0,2 porcento. As recuperações para neomicina em amostras de medicamento foram de aproximadamente 45 mais ou menos 3,0 porcento (após SPE), indicando interferências de outros componentes. Neomicina também foi recuperada em amostras de saliva após uso do medicamento obtendo valores próximos a 0,36 mais ou menos 0,02 microgramas. Em contraste, as recuperações em amostras simuladas chegaram até 102,6 mais-menos 1,3 porcento (sem necessidade de SPE). Por fim foi feita uma avaliação comparativa de interação de AuNPs-H e nanopartículas de ouro sintetizadas com redução com citrato (AuNPs-citrato) que indicou diferença de comportamento na interação com AMG. / [en] Water-dispersed gold nanoparticles (AuNPs-H) and gold nanoparticles in the presence of surfactants cetyltrimethylammonium bromide (AuNPs-CTAB) and didecyldimethylammonium bromide (AuNPs-C10DAB) were synthesized and characterized using several techniques. The differences in the UV-Vis spectral profiles of these nanoparticles were studied monitoring the intensity and the localized surface plasmon resonance band (LSPR) maximum wavelength; these were monitored as a function of time taking into account storage conditions: under refrigeration (4 Celsius degrees) and at room-temperature (27 Celsius degrees). Anomalous (more unstable) profile was observed for AuNPs-C10DAB at 1.0 × 10-4 mol L-1. Their catalytic activities were also evaluated in the presence of 4-nitrophenol and it was shown that the most effective kinetics was observed for the system without surfactant. Finally, an interaction study with aminoglycosides (AMG) was conducted aiming the application of nanoparticles as analytical probe. Only AuNPs-H produced adequate results, indicating that the surfactant prevents interaction between AMG and the surface of the nanoparticles since at higher concentrations of CTAB or C10DAB there is no significant variation in the original probe signal in presence of AMG. An analytical method was developed based on the AuNPs-H-gentamicin and AuNPs-H-neomycin interaction taking into consideration the optimization of the parameters: AuNPs-H concentration, buffer, signal stabilization time and the AMG concentration range. In the adjusted condition for quantitative probing, each dispersion consisted of 40 percent v/v (1.2 × 10-9 mol L-1) of AuNPs-H, 1.0 mL of citrate buffer pH 4.0 (1.0 × 10-2 mol L-1) and final volume of 5.0 mL adjusted with ultrapure water addition, after appropriate micro-volumes of a stock solution of AMG (except in blank dispersion) or sample added. The spectral profiles were monitored at 511 and 681 nm, allowing theconstruction of analytical curves at 681, and at the ratio (681/511). For gentamicin, the linear range reached from 0.6 to 600 microgram L-1 with the limit of detection (LD) of 0.06 microgram L-1 . For neomycin, the linear range was 7.3 to 550 microgram L-1, with LD of 6.2 microgram L-1. The application of the method was made by determining gentamicin(fortification) in whole milk, and neomycin in control solution (simulated aqueous sample), pharmaceutical samples and saliva. In order to enable selectivity of the method it was necessary to use solid phase extraction (SPE) using a commercial SPE cartridge packed with an AMG molecular imprinted polymer. In milk samples (40 microlitre), after clean up and SPE, it was possible to quantify 1,72 plus-minus 0,03 microgram gentamicin, which is equivalent to 39,1 plus-minus 0,2 percent). Recoveries for neomycin in drug samples were approximately 45 plus-minus 3.0 percent (after SPE), indicating interferences of other components. Neomycin was also recovered in saliva samples after drug use obtaining values close to 0.36 plus-minus 0.02 microgram. In contrast, the recoveries in simulated samples reached up to 102.6 plus-minus 1.3 percent (no need for SPE). Finally, a comparative evaluation of the interaction of AuNPs-H and gold nanoparticles synthesized with reduction with citrate (AuNPs-citrato) was performed, indicating differences in terms of the interaction with AMG.

No description available.